Societe Generale upgraded shares of Reckitt Benckiser (OTCMKTS:RBGLY) from a hold rating to a buy rating in a report published on Thursday, Marketbeat.com reports.
A number of other research analysts have also weighed in on the stock. Zacks Investment Research lowered shares of Reckitt Benckiser from a hold rating to a sell rating in a research note on Wednesday, March 14th. Credit Suisse Group reiterated a neutral rating on shares of Reckitt Benckiser in a research note on Tuesday, February 20th. Finally, JPMorgan Chase & Co. reiterated a buy rating on shares of Reckitt Benckiser in a research note on Monday, December 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of Hold and a consensus target price of $21.00.
Reckitt Benckiser stock opened at $16.83 on Thursday. Reckitt Benckiser has a one year low of $15.80 and a one year high of $21.79. The company has a quick ratio of 0.67, a current ratio of 0.86 and a debt-to-equity ratio of 1.94.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright law. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3297977/reckitt-benckiser-rbgly-lifted-to-buy-at-societe-generale.html.
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl, and Strepsils brand names.
Receive News & Ratings for Reckitt Benckiser Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser and related companies with MarketBeat.com's FREE daily email newsletter.